Terms: = Kidney tumors AND BCL7A, BCL7, 605, ENSG00000110987 AND Treatment
16 results:
1. The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Real-World Multi-Institutional Analysis.
Ghatalia P; Handorf EA; Geynisman DM; Deng M; Zibelman MR; Abbosh P; Anari F; Greenberg RE; Viterbo R; Chen D; Smaldone MC; Kutikov A; Uzzo RG
J Urol; 2022 Jul; 208(1):71-79. PubMed ID: 35212574
[TBL] [Abstract] [Full Text] [Related]
2. Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombus.
Ishiyama Y; Kondo T; Tachibana H; Ishihara H; Yoshida K; Takagi T; Iizuka J; Tanabe K
Urol Oncol; 2022 Mar; 40(3):110.e11-110.e18. PubMed ID: 35027262
[TBL] [Abstract] [Full Text] [Related]
3. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.
Xiao L; Zou G; Cheng R; Wang P; Ma K; Cao H; Zhou W; Jin X; Xu Z; Huang Y; Lin X; Nie H; Jiang Q
BMC Cancer; 2021 Jun; 21(1):703. PubMed ID: 34130646
[TBL] [Abstract] [Full Text] [Related]
4. Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma.
Gubbi S; Al-Jundi M; Del Rivero J; Jha A; Knue M; Zou J; Turkbey B; Carrasquillo JA; Lin E; Pacak K; Klubo-Gwiezdzinska J; Lin FI
Front Endocrinol (Lausanne); 2020; 11():587065. PubMed ID: 33551992
[TBL] [Abstract] [Full Text] [Related]
5. Incidental Congestive Heart Failure in Patients With Aldosterone-Producing Adenomas.
Huang WC; Chen YY; Lin YH; Chen L; Lin PC; Lin YF; Liu YC; Wu CH; Chueh JS; Chu TS; Wu KD; Huang CY; Wu VC; ;
J Am Heart Assoc; 2019 Dec; 8(24):e012410. PubMed ID: 31801414
[TBL] [Abstract] [Full Text] [Related]
6. Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma.
Wood A; George S; Adra N; Chintala S; Damayanti N; Pili R
Invest New Drugs; 2020 Aug; 38(4):1108-1116. PubMed ID: 31654285
[TBL] [Abstract] [Full Text] [Related]
7. Natural history of patients with tuberous sclerosis complex related renal angiomyolipoma.
Song X; Liu Z; Cappell K; Gregory C; Said Q; Prestifilippo J; Charles H; Hulbert J; Bissler J
Curr Med Res Opin; 2017 Jul; 33(7):1277-1282. PubMed ID: 28358266
[TBL] [Abstract] [Full Text] [Related]
8. Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.
Nishino M; Giobbie-Hurder A; Hatabu H; Ramaiya NH; Hodi FS
JAMA Oncol; 2016 Dec; 2(12):1607-1616. PubMed ID: 27540850
[TBL] [Abstract] [Full Text] [Related]
9. Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart Reviews.
Pal SK; Signorovitch JE; Reichmann WM; Li N; Koo V; Liu Z; Perez JR; Vogelzang NJ
Clin Genitourin Cancer; 2016 Apr; 14(2):160-7.e3. PubMed ID: 26707954
[TBL] [Abstract] [Full Text] [Related]
10. The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China.
Zheng Y; Wang F; Wu G; Zhang L; Wang Y; Wang Z; Chen P; Wang Q; Lu J; Wang Y; Li P; Wang J; Lu X; Yuan J
Medicine (Baltimore); 2015 Dec; 94(49):e2222. PubMed ID: 26656362
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy.
Tollefson MK; Boorjian SA; Gettman MT; Rangel LJ; Bergstralh EJ; Karnes RJ
Urol Oncol; 2013 Nov; 31(8):1483-8. PubMed ID: 22578510
[TBL] [Abstract] [Full Text] [Related]
12. Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer.
van der Veldt AA; Vroling L; de Haas RR; Koolwijk P; van den Eertwegh AJ; Haanen JB; van Hinsbergh VW; Broxterman HJ; Boven E
Int J Cancer; 2012 Aug; 131(4):E484-93. PubMed ID: 21953673
[TBL] [Abstract] [Full Text] [Related]
13. Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma.
Hollenbeak CS; Nikkel LE; Schaefer EW; Alemao E; Ghahramani N; Raman JD
J Manag Care Pharm; 2011 Oct; 17(8):610-20. PubMed ID: 21942302
[TBL] [Abstract] [Full Text] [Related]
14. Robot-assisted versus standard laparoscopic partial nephrectomy: comparison of perioperative outcomes from a single institution.
Cho CL; Ho KL; Chu SS; Tam PC
Hong Kong Med J; 2011 Feb; 17(1):33-8. PubMed ID: 21282824
[TBL] [Abstract] [Full Text] [Related]
15. Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients.
Yamanaka T; Matsumoto S; Teramukai S; Ishiwata R; Nagai Y; Fukushima M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):335-43. PubMed ID: 17922276
[TBL] [Abstract] [Full Text] [Related]
16. [Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil].
Yamada Y
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():37-41. PubMed ID: 16897970
[TBL] [Abstract] [Full Text] [Related]